Interleukin-22 Regulates the Complement System to Promote Resistance against Pathobionts after Pathogen-Induced Intestinal Damage

Immunity

Volumn 41, Issue 4, 2014, Pages 620-632

  Hasegawa, Mizuho ^a   Yada, Shoko ^a,b   Liu, MengZhen ^a   Kamada, Nobuhiko ^a   Muñoz Planillo, Raúl ^a   Do, Nhu ^a   Núñez, Gabriel ^a   Inohara, Naohiro ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COMPLEMENT COMPONENT C3; INTERLEUKIN 17; INTERLEUKIN 22; COBROTOXIN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; SNAKE VENOM;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; INFLAMMATORY CELL; INTESTINE FLORA; INTESTINE INJURY; KLEBSIELLA PNEUMONIAE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGEN LOAD; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TH17 CELL; TH22 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; ENTEROBACTERIACEAE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE; KNOCKOUT MOUSE; MICROFLORA; MORTALITY; PEPTOCLOSTRIDIUM DIFFICILE; PSEUDOMEMBRANOUS COLITIS;

ANIMALS; CLOSTRIDIUM DIFFICILE; COBRA VENOMS; COMPLEMENT C3; ENTEROBACTERIACEAE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; INTERLEUKINS; INTESTINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIOTA; PHAGOCYTOSIS;

EID: 84908121712     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.09.010     Document Type: Article

References (41)

1. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., Reinhart T.A., McAllister F., Edeal J., Gaus K., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008, 14:275-281.
2. Basu R., O'Quinn D.B., Silberger D.J., Schoeb T.R., Fouser L., Ouyang W., Hatton R.D., Weaver C.T. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012, 37:1061-1075.
3. Behnsen J., Jellbauer S., Wong C.P., Edwards R.A., George M.D., Ouyang W., Raffatellu M. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity 2014, 40:262-273.
4. Brandl K., Plitas G., Schnabl B., DeMatteo R.P., Pamer E.G. MyD88-mediated signals induce the bactericidal lectin RegIII γ and protect mice against intestinal Listeria monocytogenes infection. J.Exp. Med. 2007, 204:1891-1900.
5. Carroll K.C., Bartlett J.G. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu. Rev. Microbiol. 2011, 65:501-521.
6. Chen X., Katchar K., Goldsmith J.D., Nanthakumar N., Cheknis A., Gerding D.N., Kelly C.P. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008, 135:1984-1992.
7. Chow J., Mazmanian S.K. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 2010, 7:265-276.
8. D'Auria K.M., Kolling G.L., Donato G.M., Warren C.A., Gray M.C., Hewlett E.L., Papin J.A. Invivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B. Infect. Immun. 2013, 81:3814-3824.
9. Eaton S.R., Mazuski J.E. Overview of severe Clostridium difficile infection. Crit. Care Clin. 2013, 29:827-839.
10. Hasegawa M., Osaka T., Tawaratsumida K., Yamazaki T., Tada H., Chen G.Y., Tsuneda S., Núñez G., Inohara N. Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development. Infect. Immun. 2010, 78:639-650.
11. Hasegawa M., Yamazaki T., Kamada N., Tawaratsumida K., Kim Y.G., Núñez G., Inohara N. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J.Immunol. 2011, 186:4872-4880.
12. Hasegawa M., Kamada N., Jiao Y., Liu M.Z., Núñez G., Inohara N. Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop. J.Immunol. 2012, 189:3085-3091.
13. Kamada N., Seo S.U., Chen G.Y., Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13:321-335.
14. Koenigsknecht M.J., Young V.B. Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs. Curr. Opin. Gastroenterol. 2013, 29:628-632.
15. Kozich J.J., Westcott S.L., Baxter N.T., Highlander S.K., Schloss P.D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 2013, 79:5112-5120.
16. Kuehne S.A., Cartman S.T., Heap J.T., Kelly M.L., Cockayne A., Minton N.P. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010, 467:711-713.
17. Laudisi F., Spreafico R., Evrard M., Hughes T.R., Mandriani B., Kandasamy M., Morgan B.P., Sivasankar B., Mortellaro A. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J.Immunol. 2013, 191:1006-1010.
18. Liang S.C., Nickerson-Nutter C., Pittman D.D., Carrier Y., Goodwin D.G., Shields K.M., Lambert A.J., Schelling S.H., Medley Q.G., Ma H.L., et al. IL-22 induces an acute-phase response. J.Immunol. 2010, 185:5531-5538.
19. Liu B., Wei L., Meyerle C., Tuo J., Sen H.N., Li Z., Chakrabarty S., Agron E., Chan C.C., Klein M.L., et al. Complement component C5a promotes expression of IL-22 and IL-17 from human Tcells and its implication in age-related macular degeneration. J.Transl. Med. 2011, 9:1-12.
20. Lo Vecchio A., Cohen M.B. Fecal microbiota transplantation forClostridium difficile infection: benefits and barriers. Curr. Opin. Gastroenterol. 2014, 30:47-53.
21. Mundy R., MacDonald T.T., Dougan G., Frankel G., Wiles S. Citrobacter rodentium of mice and man. Cell. Microbiol. 2005, 7:1697-1706.
22. Nanjappa V., Thomas J.K., Marimuthu A., Muthusamy B., Radhakrishnan A., Sharma R., Ahmad Khan A., Balakrishnan L., Sahasrabuddhe N.A., Kumar S., et al. Plasma Proteome Database as a resource for proteomics research: 2014 update. Nucleic Acids Res. 2014, 42(Database issue):D959-D965.
23. Noris M., Remuzzi G. Overview of complement activation and regulation. Semin. Nephrol. 2013, 33:479-492.
24. Pham T.A., Lawley T.D. Emerging insights on intestinal dysbiosis during bacterial infections. Curr. Opin. Microbiol. 2014, 17:67-74.
25. Radaeva S., Sun R., Pan H.N., Hong F., Gao B. Interleukin 22 (IL-22) plays a protective role in Tcell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004, 39:1332-1342.
26. Rautemaa R., Meri S. Complement-resistance mechanisms of bacteria. Microbes Infect. 1999, 1:785-794.
27. Roberts I.S. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 1996, 50:285-315.
28. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9:313-323.
29. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7:526-536.
30. Sa S.M., Valdez P.A., Wu J., Jung K., Zhong F., Hall L., Kasman I., Winer J., Modrusan Z., Danilenko D.M., Ouyang W. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J.Immunol. 2007, 178:2229-2240.
31. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention J.J., Thiam K., Cerf-Bensussan N., Mandelboim O., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
32. Schloss P.D., Westcott S.L., Ryabin T., Hall J.R., Hartmann M., Hollister E.B., Lesniewski R.A., Oakley B.B., Parks D.H., Robinson C.J., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 2009, 75:7537-7541.
33. Schonthaler H.B., Guinea-Viniegra J., Wculek S.K., Ruppen I., Ximénez-Embún P., Guío-Carrión A., Navarro R., Hogg N., Ashman K., Wagner E.F. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity 2013, 39:1171-1181.
34. Schulz S.M., Köhler G., Schütze N., Knauer J., Straubinger R.K., Chackerian A.A., Witte E., Wolk K., Sabat R., Iwakura Y., et al. Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J.Immunol. 2008, 181:7891-7901.
35. Sonnenberg G.F., Fouser L.A., Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 2011, 12:383-390.
36. Sonnenberg G.F., Monticelli L.A., Alenghat T., Fung T.C., Hutnick N.A., Kunisawa J., Shibata N., Grunberg S., Sinha R., Zahm A.M., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012, 336:1321-1325.
37. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., Lambris J.D. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J.Exp. Med. 2003, 198:913-923.
38. Sunenshine R.H., McDonald L.C. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve. Clin. J. Med. 2006, 73:187-197.
39. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta Tcells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
40. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
41. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14:282-289.